| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |